Related Experiment Video

Updated: Mar 1, 2026

The In ovo CAM-assay as a Xenograft Model for Sarcoma
12:44

The In ovo CAM-assay as a Xenograft Model for Sarcoma

Published on: July 17, 2013

26.4K

The Current Landscape of Early Drug Development for Patients With Sarcoma

Breelyn A Wilky1, Robin L Jones1, Vicki L Keedy1

  • 1From the Sylvester Comprehensive Cancer Center, Miami, FL; Royal Marsden Hospital, The Institute of Cancer Research, London, United Kingdom; Vanderbilt University Medical Center, Nashville, TN.

American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|June 1, 2017
PubMed

Insights

Recent advancements offer new hope for adult soft tissue sarcoma patients. Novel therapies targeting growth factors, angiogenesis, and immune checkpoints are under investigation for these rare cancers.

Area of Science:

  • Oncology
  • Medical Research

Background:

  • Adult soft tissue sarcomas are rare and heterogeneous, leading to slow treatment advancements.
  • Understanding sarcoma biology has spurred the development of novel therapeutic strategies.

Purpose of the Study:

  • To review current and emerging treatment strategies for adult soft tissue sarcomas.
  • To highlight the importance of recognizing sarcoma histologies as distinct diseases and the availability of clinical trials.

Main Methods:

  • Review of current literature on adult soft tissue sarcoma treatments.
  • Discussion of novel therapeutic targets including PDGFRα, mTOR, and angiogenesis.
  • Exploration of the role of checkpoint inhibitors in sarcoma treatment.

Main Results:

  • Novel cytotoxic chemotherapies are being investigated.
  • Targeted agents and immunotherapies show promise in clinical trials.
  • Recognizing distinct sarcoma histologies is crucial for effective treatment.

Conclusions:

  • The field of adult soft tissue sarcoma treatment is evolving with new therapeutic avenues.
  • Awareness of ongoing clinical trials is vital for patients with these rare malignancies.

More Related Videos

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

15.3K
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.7K

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.2K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.4K